SCHEMBL31496929

SCHEMBL31496929

O=c1[nH]nc(CCl)c2cc(Br)cc(OC(F)F)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.34
▸ WDR77 Q9BQA1 2/20 0.34
▸ HTT P42858 1/20 0.32
▸ PDE3B Q13370 3/20 0.31
▸ PDE3A Q14432 3/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ PDE1A P54750 1/20 0.31
▸ PDE1B Q01064 1/20 0.31
▸ PDE1C Q14123 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ CYP2C9 P11712 2/20 0.30
▸ TSHR P16473 2/20 0.30
▸ CYP2C19 P33261 2/20 0.30
▸ PDE4A P27815 2/20 0.30
▸ PDE4B Q07343 2/20 0.30
▸ PDE4C Q08493 2/20 0.30
▸ PDE4D Q08499 2/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30970711 0.81 ADORA1 (0.38) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL27002463 0.81 ADORA1 (0.38) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL27002284 0.81 PRMT5 (0.35) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL29915079 0.81 PRMT5 (0.35) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL31496831 0.79 PRMT5 (0.60) PRMT5WDR77CYP2C9TSHRCYP2C19
SCHEMBL30752851 0.78 PRMT5 (0.39) PRMT5WDR77HTTCYP2C9TSHR
SCHEMBL30752919 0.78 PARP1 (0.32) PARP1
SCHEMBL23087315 0.77 AR (0.41) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL25219373 0.76 PRMT5 (0.35) PRMT5WDR77HTTPDE3BPDE3A
SCHEMBL30833177 0.76 PRMT5 (0.35) PRMT5WDR77HTTPDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585261-A PRMT5 inhibitor, preparation method and application thereof 上海艾力斯医药科技股份有限公司 2025-03-07 — — CN disclosed
Send feedback